About this product

This Inactivated Porcine Parvovirus Vaccine, utilizing the specific Strain S-1, is a crucial biological product engineered for the prevention of Porcine Parvovirus (PPV) infection in swine. Its primary function is to stimulate a robust immune response in pigs, thereby conferring protection against the debilitating effects of PPV, a significant pathogen causing reproductive failures and economic losses in swine herds. The vaccine's inactivated nature ensures safety by eliminating the risk of live virus replication while still eliciting a potent humoral immunity. While specific technical specifications are not detailed, inactivated vaccines are typically formulated for optimal antigen presentation and stability. The vaccine is manufactured under stringent quality control measures to ensure efficacy and batch-to-batch consistency. It is available in standard veterinary vaccine formulations, suitable for intramuscular injection. Typical applications include routine vaccination programs for breeding sows and gilts to protect them and their offspring from PPV. This product is ideal for importers, wholesalers, and distributors serving the global swine farming industry, including large-scale commercial operations and veterinary pharmaceutical suppliers. Its efficacy in preventing a widespread swine disease makes it a valuable commodity for international trade, addressing a critical need within the global animal health sector.